specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility
Closed Pre-Solicitation Posted
- Solicitation number
- 26-002367
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center is seeking specialized consultants to conduct a feasibility review and develop a business plan for establishing a viral vector manufacturing facility within an existing cell manufacturing facility. The facility will produce retroviral/lentiviral vectors, adeno-associated viruses (AAV), and prepare for future nanoparticle manufacturing to support Phase I and early Phase II clinical studies at the NIH Clinical Center. This procurement will be conducted under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, which allows for single-source contracting when deemed appropriate. Interested parties must submit their capabilities and interest by the closing date of March 10, 2026, to Susan Nsangou, Contracting Officer, at susan.nsangou@nih.gov. The government reserves sole discretion in determining whether to compete this requirement based on the responses received. The contract falls under NAICS Code 541990 (All Other Professional, Scientific, and Technical Services) and PSC Category R499 (Support-Professional: Other).
No set-aside designations have been applied to this procurement, meaning it is open to all eligible contractors without preference restrictions. The notice does not identify any current incumbents or existing contractors supporting this function. The pre-solicitation announcement does not disclose the potential award value or budget range for this engagement. No specific timeline for service completion is detailed in the notice, though the feasibility review and business plan development are expected to inform future facility development decisions. Since this is a notice of intent rather than a formal solicitation, no formal request for quotations will be issued, and the government maintains complete discretion over procurement decisions based on the interest and qualifications demonstrated by responding parties.
Notice text
Notice Number: NOI-CC-26-002367
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility. The manufacturing will encompass retroviral/lentiviral vectors, AAV and transition to future nanoparticles for Phase I and early Phase II studies conducted at the NIH Clinical Center.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Susan Nsangou, Contracting Officer via email to susan.nsangou@nih.gov by close date.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| AJ12--Development/Production - Kidney GEC-Specific AAV Vector | Veterans Integrated Service Network 4 | No set-aside | |
| National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity